News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
357,556 Results
Type
Article (18922)
Company Profile (82)
Press Release (338549)
Multimedia
Podcasts (48)
Webinars (7)
Section
Business (95468)
Career Advice (1388)
Deals (18397)
Drug Delivery (47)
Drug Development (53823)
Employer Resources (66)
FDA (8842)
Job Trends (7465)
News (175107)
Policy (15081)
Tag
2027 Biotech Bay Standard (1)
2027 Genetown Elite (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (1)
Academia (1304)
Accelerated approval (22)
Adcomms (14)
Allergies (105)
Alliances (19923)
ALS (119)
Alzheimer's disease (969)
Antibody-drug conjugate (ADC) (257)
Approvals (9181)
Artificial intelligence (335)
Autoimmune disease (116)
Automation (24)
Bankruptcy (141)
Best Places to Work (6348)
BIOSECURE Act (6)
Biosimilars (137)
Biotechnology (54)
Bladder cancer (142)
Brain cancer (49)
Breast cancer (552)
Cancer (3885)
Cardiovascular disease (306)
Career advice (1095)
Career pathing (16)
CAR-T (192)
CDC (19)
Celiac Disease (1)
Cell therapy (515)
Cervical cancer (27)
Clinical research (48291)
Collaboration (1177)
Company closure (3)
Compensation (810)
Complete response letters (36)
COVID-19 (2281)
CRISPR (62)
C-suite (516)
Cystic fibrosis (83)
Data (5154)
Denatured (7)
Depression (93)
Diabetes (362)
Diagnostics (3833)
Digital health (31)
Diversity (5)
Diversity, equity & inclusion (13)
Drug discovery (173)
Drug pricing (68)
Drug shortages (11)
Duchenne muscular dystrophy (174)
Earnings (56218)
Editorial (22)
Employer branding (8)
Employer resources (57)
Events (57974)
Executive appointments (621)
FDA (11256)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (8)
Frontotemporal dementia (17)
Funding (1008)
Gene editing (133)
Generative AI (21)
Gene therapy (418)
GLP-1 (648)
Government (2287)
Grass and pollen (6)
Guidances (363)
Healthcare (9467)
HIV (51)
Huntington's disease (36)
IgA nephropathy (72)
Immunology and inflammation (167)
Immuno-oncology (51)
Indications (87)
Infectious disease (2476)
Inflammatory bowel disease (125)
Inflation Reduction Act (11)
Influenza (90)
Intellectual property (156)
Interviews (255)
IPO (10607)
IRA (20)
Job creations (1438)
Job search strategy (949)
JPM (28)
Kidney cancer (17)
Labor market (57)
Layoffs (297)
Leadership (22)
Legal (2702)
Liver cancer (70)
Longevity (5)
Lung cancer (526)
Lymphoma (331)
Machine learning (24)
Management (21)
Manufacturing (427)
MASH (142)
Medical device (6880)
Medtech (6911)
Mergers & acquisitions (8609)
Metabolic disorders (902)
Multiple sclerosis (130)
NASH (17)
Neurodegenerative disease (224)
Neuropsychiatric disorders (71)
Neuroscience (1855)
NextGen: Class of 2026 (2746)
Non-profit (2298)
Now hiring (22)
Obesity (392)
Opinion (130)
Ovarian cancer (135)
Pain (153)
Pancreatic cancer (198)
Parkinson's disease (197)
Partnered (15)
Patents (298)
Patient recruitment (360)
Peanut (42)
People (20802)
Pharmaceutical (19)
Pharmacy benefit managers (13)
Phase 1 (12896)
Phase 2 (20178)
Phase 3 (19652)
Pipeline (4415)
Policy (99)
Postmarket research (1426)
Preclinical (4714)
Press Release (20)
Prostate cancer (197)
Psychedelics (24)
Radiopharmaceuticals (155)
Rare diseases (593)
Real estate (2010)
Recruiting (27)
Regulatory (13137)
Reports (35)
Research institute (1221)
Resumes & cover letters (262)
Rett syndrome (22)
RNA editing (11)
RSV (62)
Schizophrenia (125)
Series A (151)
Series B (132)
Service/supplier (7)
Sickle cell disease (72)
Special edition (22)
Spinal muscular atrophy (113)
Sponsored (24)
Startups (1530)
Stomach cancer (9)
Supply chain (63)
Tariffs (37)
The Weekly (41)
Vaccines (731)
Venture capital (59)
Weight loss (233)
Women's health (62)
Worklife (11)
Date
Today (2)
Last 7 days (444)
Last 30 days (1460)
Last 365 days (22410)
2026 (2436)
2025 (22751)
2024 (22759)
2023 (24263)
2022 (30419)
2021 (32443)
2020 (30717)
2019 (22465)
2018 (16988)
2017 (17766)
2016 (15579)
2015 (18285)
2014 (13409)
2013 (10256)
2012 (10942)
2011 (11481)
2010 (9882)
Location
Africa (425)
Alabama (39)
Alaska (3)
Arizona (97)
Arkansas (8)
Asia (24001)
Australia (4361)
California (8667)
Canada (2218)
China (830)
Colorado (360)
Connecticut (374)
Delaware (279)
Europe (51964)
Florida (999)
Georgia (249)
Hawaii (3)
Idaho (24)
Illinois (594)
India (42)
Indiana (343)
Iowa (11)
Japan (392)
Kansas (80)
Kentucky (14)
Louisiana (17)
Maine (44)
Maryland (830)
Massachusetts (5901)
Michigan (131)
Minnesota (394)
Mississippi (6)
Missouri (89)
Montana (12)
Nebraska (8)
Nevada (93)
New Hampshire (46)
New Jersey (2259)
New Mexico (9)
New York (2084)
North Carolina (985)
North Dakota (5)
Northern California (4288)
Ohio (224)
Oklahoma (9)
Oregon (23)
Pennsylvania (1540)
Puerto Rico (12)
Rhode Island (23)
South America (656)
South Carolina (29)
Southern California (3391)
Tennessee (98)
Texas (1275)
United States (28436)
Utah (179)
Virginia (187)
Washington D.C. (41)
Washington State (648)
West Virginia (2)
Wisconsin (104)
Wyoming (1)
357,556 Results for "3 v biosciences".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Twist Bioscience Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4) - February 3, 2026
February 4, 2026
·
2 min read
Press Releases
Vivoryon Therapeutics N.V. Reports Q3 2025 Financial Results and Business Updates
December 4, 2025
·
10 min read
Press Releases
Locus Biosciences Awarded $3.3 Million from NIH to Support Clinical Trial of AI-Designed Bacteriophage Therapy for Pneumonia caused by Antibiotic Resistant Bacteria
January 8, 2026
·
3 min read
Press Releases
Neurocrine Biosciences Provides Update on Phase 3 Study of Valbenazine in Dyskinetic Cerebral Palsy
December 23, 2025
·
6 min read
Press Releases
SOFIE Biosciences Announces First Patient Dosed in [18F]FAPI-74 Phase 3 Study for Pancreatic Cancer
February 11, 2026
·
3 min read
Press Releases
Enveric Biosciences Announces Exercise of Warrants for $3.1 Million Gross Proceeds
December 12, 2025
·
5 min read
Press Releases
Enveric Biosciences Announces Closing of Exercise of Warrants for $3.1 Million Gross Proceeds
December 15, 2025
·
5 min read
Press Releases
QIAGEN N.V. to Release Results for Q3 2025 and Hold Webcast
October 14, 2025
·
1 min read
Press Releases
Vivoryon Therapeutics N.V. to Report Q3 2025 Financial Results and Operational Progress on December 4, 2025
November 25, 2025
·
3 min read
Press Releases
Daré Bioscience Receives $3.6 Million in Additional Grant Funding
November 24, 2025
·
10 min read
1 of 35,756
Next
